Our Team
Victor Chen, MD, MPH
Assistant Professor
Department of Radiation Oncology
Day hiker, boba drinker, board gamer
Meet Dr. Chen
Each patient has a unique story to tell, and I am privileged to be entrusted with guiding them through their medical journey.
Dr. Victor Chen is a general radiation oncologist who treats patients with all types of cancers. He has a particular interest in malignancies of the prostate, breast, lung, and central nervous system. Dr. Chen received his undergraduate degree in biology from the California Institute of Technology (Caltech) and his medical degree from UC San Diego as part of the Caltech-UCSD Medical Scholars Program. He subsequently completed his internship in general surgery at Harbor-UCLA Medical Center and his residency in radiation oncology at Thomas Jefferson University. Concurrently during his time in residency training, he also obtained a masters in public health at Thomas Jefferson University.
Dr. Chen’s research interests focus on the intersection of public health and cancer treatment, such as in the areas of health disparities and cost-effectiveness. He primarily treats patients at the UCSF-Washington Hospital Radiation Oncology Center in Fremont, CA.
 |
Education
|
 |
Professional Experience
|
 |
Awards & Honors
|
 |
Chen VE, Kim M, Nelson N, Kim IK, Shi W. “Cost-effectiveness analysis of 3 radiation treatment strategies for patients with multiple brain metastases.” Neuro-Oncology Practice. 2023 Aug;10(4): 344-351. doi: 10.1093/nop/npac093 Chen VE, Lombardo JF, Castaneda SA, Winkfield KM, Fisher SA, Gressen EL, Rudoler SB, Yan W, Gajjar SR. “Disparities in lung cancer for Black patients in the US: An overview of contributing factors and potential strategies for radiation oncologists to bridge the gap.” Applied Radiation Oncology. 2020 Ali AS, Chen VE, Zurlo C, Taylor JM, Fernandez C, Shi W. “Target treatment with stereotactic radiation for recurrent gliomas.” Chinese Clinical Oncology. 2020 Dec;9(6): 74. doi: 10.21037/cco.2020.03.05 Taylor JM, Chen VE, Miller RC, Greenberger BA. “The impact of prostate cancer treatment on quality of life: a narrative review with a focus on randomized data.” Research and Reports in Urology. 2020 Oct;12: 533-546. doi: 10.2147/RRU.S243088 Chen VE, Greenberger BA, Taylor JM, Edelman MJ, Lu B. “The underappreciated role of the humoral immune system and B cells in tumorigenesis and cancer therapeutics: a review.” International Journal of Radiation Oncology*Biology*Physics. 2020 Sep;108(1): 38-45. doi: 10.1016/j.ijrobp.2020.03.022 Taylor JM, Song A, David AR, Chen VE, Lu B, Werner-Wasik M. “Impact of sarcopenia on survival in patients with early-stage lung cancer treated with stereotactic body radiation therapy.” Cureus. 2020 Sep;12(9): e10712. doi: 10.7759/cureus.10712 Chen VE, Greenberger BA, Shi Z, Gajjar S, Shi W, Mourad WF, Yan W. “Post-mastectomy and post- breast conservation surgery pain syndrome: a review of etiologies, risk prediction, and trends in management.” Translational Cancer Research. 2020 Jan;9(S1): S77-S85. doi: 10.21037/tcr.2019.06.46 Greenberger BA, Taylor JM, Chen VE, Den RB. “Comparing radiotherapy to prostatectomy for high-risk prostate cancer: a narrative review of mortality and quality of life outcomes.” The Cancer Journal. 2020 Jan;26(1): 29-37. doi: 10.1097/PPO.0000000000000420 Greenberger BA, Chen VE, Den RB. “Combined modality therapies for high-risk prostate cancer: narrative review of current understanding and new directions.” Frontiers in Oncology – Genitourinary Oncology. 2019 Nov;9: 1273. doi: 10.3389/fonc.2019.01273 Chen VE, Greenberger BA, Taylor JM, Lu B. “Key immune system markers in immunotherapy: absolute lymphocyte count, neutrophil to lymphocyte ratio, and alternative immune system metrics.” Therapeutic Radiology and Oncology. 2019 Sep;3(33). doi: 10.21037/tro.2019.09.01 Chen VE, Gillespie EF, Manger RP, Skerritt LA, Tran JH, Proudfoot JA, Sherer MV, Einck JP, Mell LK, Moore KL, Yashar CM. “The impact of daily bladder filling on small bowel dose for intensity modulated radiation therapy for cervical cancer.” Medical Dosimetry. 2019 Jun;44(2): 102-6. doi: 10.1016/j.meddos.2018.02.010 Chen VE, Gillespie EF, Zakeri K, Murphy JD, Yashar CM, Lu S, Einck JP. “Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer.” Advances in Radiation Oncology. 2017 Apr;2(2): 105-9. doi: 10.1016/j.adro.2017.01.012 Pierry D, Weiss G, Lack B, Chen V, Fusco J. “Intracellular human papillomavirus E6, E7 mRNA quantification predicts CIN 2+ in cervical biopsies better than Papanicolaou screening for women regardless of age.” Archives of Pathology & Laboratory Medicine. 2012 Aug;136(8): 956-60. doi: 10.5858/arpa.2011-0180-OA
|